Multiple Myeloma Turkish Prospective Patient Registry
NCT04143932 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2023-07-18
Summary
This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey
Conditions
- Multiple Myeloma
- Relapse Multiple Myeloma
Sponsors & Collaborators
-
Turkish Hematology Association
lead OTHER
Principal Investigators
-
Omur Gokmen Sevindik, Assoc. Prof. · Medipol University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-10
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
GMMG Multiple Myeloma Registry
NCT07111884 ·Status: RECRUITING
-
The Molecular Characterization of Multiple Myeloma at Relapse
NCT00639054 ·Status: COMPLETED
-
A Registry Study of Participants With Multiple Myeloma in Latin America
NCT03955900 ·Status: COMPLETED
-
Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
NCT01109407 ·Status: TERMINATED
-
Multiple Myeloma Patient Registry
NCT03180853 ·Status: TERMINATED
-
Survival Outcomes of Multiple Myeloma Patients Admitted on Assiut Clinical Hematology Unit
NCT05119205 ·Status: UNKNOWN
-
Stem Cell Translpantation in Multiple Myeloma
NCT05082675 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
NCT01058434 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Research in Multiple Myeloma
NCT00572338 ·Status: COMPLETED
-
Immune Profiling in Multiple Myeloma
NCT04135079 ·Status: COMPLETED
-
A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma
NCT01302392 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis
NCT03506386 ·Status: COMPLETED
-
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
NCT06365060 ·Status: RECRUITING
-
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
NCT02761187 ·Status: TERMINATED
-
S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
NCT00900263 ·Status: COMPLETED
-
Anonymization of Clinical Data From Pseudonymized Databases Collected as Part of Previus Clinical Trials on Multiple Myeloma
NCT07283224 ·Status: RECRUITING
-
A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
NCT05160584 ·Status: RECRUITING
-
Immunophenotyping of Plasma Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From Multiple Myeloma (MM) Patients
NCT05428163 ·Status: COMPLETED
-
Autologous Transplantation for Multiple Myeloma
NCT00378222 ·Status: COMPLETED ·Phase: PHASE3
-
S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
NCT00919139 ·Status: COMPLETED
-
Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma
NCT05190263 ·Status: COMPLETED
-
Multiple Myeloma Minimal Residual Disease
NCT02627261 ·Status: COMPLETED
-
A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence
NCT06767254 ·Status: RECRUITING
-
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
NCT01838512 ·Status: ACTIVE_NOT_RECRUITING
-
Helical Tomotherapy in Multiple Myeloma
NCT05970198 ·Status: RECRUITING ·Phase: NA